937 results on '"Watz, Henrik"'
Search Results
2. Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET
3. Selective androgen receptor modulation for muscle weakness in chronic obstructive pulmonary disease: a randomised control trial
4. Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity.
5. Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities
6. Decline of COPD exacerbations in clinical trials over two decades -- a systematic review and meta-regression
7. Lymphangioleiomyomatose
8. Körperliche Aktivität bei chronisch obstruktiver Lungenerkrankung – jeder Schritt zählt
9. Association of coronary artery calcification with clinical and physiological characteristics in patients with COPD: Results from COSYCONET
10. Longitudinal Impact of Sputum Inflammatory Phenotypes on Small Airway Dysfunction and Disease Outcomes in Asthma
11. Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial
12. The arginine methyltransferase PRMT7 promotes extravasation of monocytes resulting in tissue injury in COPD
13. Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET
14. Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment
15. IgE is associated with exacerbations and lung function decline in COPD
16. Cardiovascular predictors of mortality and exacerbations in patients with COPD
17. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
18. Differential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications: Results From the COPD and Systemic Consequences-Comorbidities Network
19. Auswirkungen von erhitzten Tabakerzeugnissen, E-Zigaretten und brennenden Zigaretten auf die kleinen Atemwege und die arterielle Steifigkeit
20. Small Airway Dysfunction Links Asthma Severity with Physical Activity and Symptom Control
21. COPD maintenance medication is linked to left atrial size: Results from the COSYCONET cohort
22. Inhaled long-acting muscarinic antagonists in asthma – A narrative review
23. Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
24. Measurement of urinary Dickkopf-3 uncovered silent progressive kidney injury in patients with chronic obstructive pulmonary disease
25. Expiratory Venous Volume and Arterial Tortuosity are Associated with Disease Severity and Mortality Risk in Patients with COPD: Results from COSYCONET.
26. Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET
27. Real-world walking cadence in people with COPD
28. Real-World Characteristics of Patients with Severe Asthma prior to Starting Dupilumab: The ProVENT Study
29. Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET
30. Investigating the prognostic value of digital mobility outcomes in patients with chronic obstructive pulmonary disease: a systematic literature review and meta-analysis
31. Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET
32. Genetic evidence for a causative effect of airflow obstruction on left ventricular filling: a Mendelian randomisation study
33. CAT score single item analysis in patients with COPD: Results from COSYCONET
34. Assessment of Physical Activity
35. Safety and efficacy of the human neutrophil elastase inhibitor BAY 85-8501 for the treatment of non-cystic fibrosis bronchiectasis: A randomized controlled trial
36. Anti-inflammatory effects of roflumilast in chronic obstructive pulmonary disease (ROBERT): a 16-week, randomised, placebo-controlled trial
37. Midregional pro atrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all- cause mortality in early COPD – Results from COSYCONET
38. Minimal Clinically Important Difference for Impulse Oscillometry in Adults with Asthma
39. Clinical factors linked to the type of respiratory medication in COPD: Results from COSYCONET
40. Proteasome function as a biomarker for severe COPD endotypes
41. Study design of a Phase 2 rollover trial of the novel cathepsin C inhibitor BI 1291583 in patients with bronchiectasis
42. Telemonitoring of Symptoms and Lung Function in COPD for Early Detection of Exacerbations
43. Impact of heated tobacco products, e-cigarettes, and combustible cigarettes on small airways and arterial stiffness
44. Inhaled Ensifentrine, decreased healthcare research utilization and reduced moderate exacerbation rate and risk in COPD over 24 Weeks
45. Laboratory and free-living gait performance in adults with COPD and healthy controls
46. Clinical validation of real-world walking cadence in patients with COPD
47. Impact of Heated Tobacco Products, E-Cigarettes, and Combustible Cigarettes on Small Airways and Arterial Stiffness
48. Effects of pharmacological and non-pharmacological interventions on physical activity outcomes in COPD: a systematic review and meta-analysis
49. Estimating the Health and Economic Impact of Improved Management in Prevalent Chronic Obstructive Pulmonary Disease Populations in England, Germany, Canada, and Japan: A Modelling Study
50. Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.